We are live on ! Find out more
KXA

KPCB XIV Associates Portfolio holdings

AUM $42.8M
1-Year Est. Return 16.52%
This Fund
S&P 500
This Quarter Est. Return
+43.21%
1 Year Est. Return
-16.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$11.6M
AUM Growth
-$255M
Cap. Flow
-$259M
Cap. Flow %
-2,229.99%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
BYND icon
Beyond Meat
BYND
+$259M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OYST
1
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$11.6M 100%
367,987
BYND icon
2
Beyond Meat
BYND
$283M
-3,419,321
Closed -$259M

Similar funds

KPCB XIV Associates's Q1 2020 Portfolio in Review

As of Q1 2020, KPCB XIV Associates held 2 positions worth $11.6M, down 96% from $267M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XIV Associates withdrew a net $259M in Q1 2020, closing 1 position. Its most notable exit was Beyond Meat, an estimated $259M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 3% a quarter earlier, followed by Consumer Staples.

  • KPCB XIV Associates fully exited Beyond Meat in Q1 2020, selling an estimated $259M.
  • KPCB XIV Associates's ten largest holdings make up 100% of its $11.6M portfolio in Q1 2020.
  • KPCB XIV Associates opened 0 new positions and closed 1 in Q1 2020.
  • KPCB XIV Associates's portfolio value fell 96% quarter-over-quarter to $11.6M.

Based on KPCB XIV Associates's 13F filing for Q1 2020, filed 10 Apr 2020.